Paul Laikind, ViaCyte CEO
Stem cell player ViaCyte expands collaboration with Gore to develop subcutaneous diabetes treatment
Longtime stem cell player ViaCyte has teamed up with a materials science company in an effort to solve immunosuppression challenges and advance its type 1 …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.